The global manual resuscitators market size was valued at USD 486.5 million in 2021 and is expected to reach USD 753.44 million in 2030 expanding at a compound annual growth rate (CAGR) of 5.62% from 2022 to 2030.
For the purpose of providing manual ventilation to a patient, a manual resuscitator is a single piece of equipment that includes a mechanism for preventing rebreathing, a self-inflating bag, and a reservoir for oxygen. An unconscious person who can't breathe or is having great trouble breathing may be kept alive and oxygenated by using a device called a manual resuscitator. This equipment is used to manually inflate the lungs of the unconscious person.
In other words, when a ventilator is not available for treatments such as chest compressions or suctioning, manual resuscitators are used to standardise the supply of sufficient breathing and enough oxygen concentrations in the patient.
Over the course of the next time period, it is projected that the market for manual resuscitators, sometimes referred to as BVM (Bag Valve Masks), would experience a meteoric rise. This can be related to an increase in the number of cases involving cardiac arrests, newborn care, and awareness programmes, as well as websites that simulate medical situations.
In order to ensure that manual resuscitators are used in a secure manner, certain precautions are now being taken. For instance, the American Heart Association (AHA), which is also known as the National Registry of Cardiopulmonary Resuscitation (NRCPR), was recently responsible for establishing this resource, which works as a multi-site data gathering source.
|Market Size||USD 753.44 million in 2030|
|Fastest Growing Market||Asia Pacific|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
The expansion of the manual resuscitators market is anticipated to be fuelled by factors such as the rising incidence of chronic obstructive pulmonary disease (COPD) as well as technological advancements in the field of resuscitators. According to the numbers that were published by the World Health Organization in June 2021, roughly 17.9 million people passed away as a result of cardiovascular illnesses in 2019. This number represented approximately 32 percent of all fatalities that occurred across the globe. In low- and middle-income nations, which account for around 75 percent of all mortality, approximately 85 percent of deaths are attributable to cardiovascular diseases such as stroke and heart attack. This will most certainly be beneficial to the expansion of the market.
The expansion of the market is anticipated to be propelled forward throughout the projected period by the growing need for newborn care. According to data provided by the Centers for Disease Control and Prevention (CDC), the rate of preterm births in the United States amounted for 10.10 percent in the year 2020 and 10.2 percent in the year 2019. In the United States, premature birth affects one baby out of every ten births. The market expansion is expected to be boosted by the rising prevalence of premature births. Delivery asphyxia is a disorder that causes a person to be unable to breathe and occurs when there is a disruption in the blood flow or the exchange of gas from the foetus during, before, or after birth. 23 percent of newborns were found to have a diagnosis of birth asphyxia in the research titled "Birth asphyxia survivors in a developing nation." Therefore, it is imperative to perform resuscitation in situations like these.
An estimated one percent of newly born infants require intensive resuscitative steps to ensure that their hearts and lungs are able to function normally, as stated by the American Heart Association (AHA), which reports that approximately ten percent of infants who have just been born require assistance with breathing at birth. Hence, effective and essential resuscitation at delivery to these children might help in fewer neonatal mortality and would support the growth of the market further.
The market for manual resuscitators is seeing competition from other devices, like as automatic resuscitators, which are becoming increasingly commonplace in medical settings. Silicon is a cost-effective material, yet it has been known to trigger allergic responses in individuals. This is a matter for worry since it may lead to asthma sufferers leading to deteriorating health issues. These considerations are contributing to a certain degree of restraint in the demand for manual resuscitators.
Innovative treatments for cardiovascular illnesses and respiratory problems are now being developed both by companies currently operating in the market and by research groups. In addition, there is current study being done specifically on this topic.
Based on region the market is divided into: North America, Europe, Asia Pacific, Latin America, and Middle East.
The largest market shares in 2021 belonged to North America with 37.9%. The rise in cardiac arrest and newborn ventilation cases might be blamed for this. For instance, the American Heart Association helped host the first virtual Resuscitation Science Symposium in the US in November 2020. The purpose of the symposium was to examine the most recent advancements in resuscitation research and to foster peer learning.
Initiatives to prevent cardiac arrest outside of a hospital are also anticipated to fuel market expansion. For instance, research networks like the Resuscitation Outcomes Consortium (ROC) are set up to investigate better ways to handle cardiac arrest and trauma situations outside of hospitals. Ten regional centres spread across the U.S. and Canada make up the clinical research network known as The ROC.
During the projection period, Asia Pacific is anticipated to have significant expansion. The National Health Mission 2015 and New-born Action Plan of the Indian government includes measures to enhance in-hospital newborn care (NAP). The Indian government was required to offer 2,706 hospitals as first referral units, 14,000 infant care corners, and 2,020 newborn stabilisation units as part of this effort. The Indian government's NAP programme intends to lower newborn fatalities to a single-digit rate by 2030. These actions should stimulate market expansion.
Due to its usefulness in hospital emergency departments such neonatal and delivery wards and the rising number of self-inflating resuscitators being released, the self-inflating category led the market with a share of 48.9% in 2021. For instance, the automated manual resuscitator Ventiv was introduced in April 2020 as a result of a partnership between the Vecna family of businesses, which also includes Vecna Healthcare, Vecna Robotics, and VecnaCares, MIT CSAIL, and 10XBeta. With Ambu bags or any other self-inflating bag, Ventiv automates the compression and relaxation of manual bags to provide consistent pressure ventilation.
To assure a flow of 100% oxygen, flow-inflating bags need an oxygen reservoir. The newborn care and intensive care units are where flow-inflating resuscitators are most commonly employed. The World Health Organization estimates that in 2020, neonatal deaths will account for almost 47% of all deaths of children under the age of five. Birth asphyxia, or the inability to breathe when born, and various birth abnormalities are the main causes of mortality. Thus, it is anticipated that sector growth would be aided by the increased occurrence of asphyxia in newborns.
Due to its advantages over flow-inflating bags, the T-piece market is anticipated to develop profitably throughout the projection period. Pediatric research found that T-piece resuscitators (TPR) in 2020 offered more reliable peak inspiratory pressure when compared to Self-Inflating Bags (SIBs). Positive end-expiratory pressure (PEEP) supply varies based on the selected PEEP, respiratory rate, gas flow, and SIB + PEEP valve model. SIBs often provide less PEEP than the needed and established norms.
During the projection period, the segment is expected to have significant increase. Due to their low risk of infection, disposable resuscitators are quite popular with both patients and medical personnel. The segment's rise is being fueled by an increase in cardiopulmonary diseases instances.
Reusable resuscitation bags are composed of silicone, whereas single-use or disposable bags are often made of PVC. Reusable resuscitation bags may be disinfected, cleaned, and put back together. They are often more expensive than disposable ones, but they are more cost-effective over the long run.
Reusable silicone resuscitation bags are more odourless, latex-free, and environmentally friendly. They feel better too since they are softer. These benefits are anticipated to fuel the reusable segment's expansion.
Due to its significant use in hospitals and outpatient settings for treating adult and paediatric patients with respiratory or cardiac conditions, the silicone category held the biggest market share of 45.9% in 2021.
Silicone-based manual resuscitators market are heavily used by large manufacturers, and new inventions heavily rely on them. For instance, in September 2020, Aequs introduced AQovent, a mechanical resuscitator that is silicone-based, affordable, of high medical quality, and mass-produced. It is an emergency resuscitator that automatically provides patients with steady pressure ventilation while being powered by oxygen.
PVC, on the other hand, is anticipated to see the fastest growth throughout the projection period. Even while silicone resuscitators are more expensive than PVC or rubber ones, throughout the course of usage, they are more cost-effective than disposable ones. As a result, PVC is increasingly becoming more in demand.
The market is divided into pop-off valves, PEEP valves, and other products based on technology. The majority of resuscitators simply have pressure valves and have a slot for a PEEP valve, hence they belong to other groups. Adult patients are often treated for medical conditions using resuscitators alone with the pressure valve.
Due to the patients' increased oxygen needs during the COVID-19 epidemic, the PEEP valve receives more attention. Patients who needed more oxygen than 0.5 FiO2 were advised to utilise a PEEP valve in conjunction with manual resuscitators to increase oxygenation. The category growth was aided by this.
Due to its widespread usage in hospitals for the treatment of adult patients, the other sector had the biggest market share in 2021. However, during the course of the projected period, it is predicted that the pop-off valve sector would expand significantly. Since the majority of newborns in NICUs require respiratory support at delivery, the demand for pop-off valves is rising.
Due to the increased frequency of cardiac and chronic obstructive pulmonary disease (COPD) in the population, which includes a sizable elderly patient pool, the adult sector retained the biggest proportion in 2021 at 44.7%.
The severe effects of COVID-19 infection on adults and increased oxygen needs for infection therapy may both contribute to the expansion of the adult segment. The oxygen needs during the COVID-19 pandemic in India were reportedly 63 percent in the first wave and 74 percent in the second wave, according to a research by Max Healthcare.
Globally, there were over 703 million individuals aged 65 or older in 2019, and that figure is projected to quadruple to 1.5 billion by 2050, according to statistics from World Population Prospects 2019. Neonates and newborns are included in the others category. Due to the increasing expenditure in neonatal intensive care to combat the growing newborn fatalities globally, the others category is predicted to have exceptional growth throughout the projected period.
The use of resuscitators during anaesthesia and for the management of ailments like asthma is covered in the other section.
Due to the growing burden of the condition, the COPD sector had the biggest market share in 2021. The third-leading cause of mortality worldwide in 2019, COPD claimed the lives of 3.23 million people, according to the WHO. In low- and middle-income nations, around 80% of these fatalities took place.
However, the sector for cardiopulmonary arrest is predicted to pick up steam and expand quickly over the course of the projection period. This is attributable to governments and authorities being more aware of the usage of manual resuscitators for cardiopulmonary therapy. The register creates a uniform system for comparing different hospitals' facilities.
The market is divided into hospital, out-of-hospital, ASC, military, and other segments based on end-use. With a 51.0% market share in 2021, hospitals led the industry. In hospitals, BVMs are utilised for newborn care, critical care, and cardiac arrest situations. The first set of criteria for evaluating, studying, and documenting in-hospital resuscitation was released by the American Health Association (AHA). In-hospital reporting is done using the Utstein Style, which was developed as an international standardised process.
Due to the growing need for bystander cardiopulmonary resuscitation and rising awareness campaigns, the out-of-hospital sector is predicted to have profitable expansion. Manual resuscitators market are becoming more necessary due to the poor survival rate of out-of-hospital CPR.
The category growth is predicted to be boosted by the increasing use of ambulatory surgery facilities. Ambulatory surgical facilities offer immediate surgical care and can help patients save time. The category is growing as a result of an increase in ASCs and cardiac arrest patients.
A portable ventilator for COVID-19 was created in April 2020 by Biodesign Innovation Labs, a company located in India. RespairAID, as it is known, makes the promise that it will alleviate the tiredness, unreliability, and inconsistency brought on by manual ventilation. Healthcare professionals may move it easily due to its compact size during crises.
The experts at Trine University and Parkview Health created a supplementary device for pumping manual resuscitators in April 2020.
To treat COVID-19 patients, Fitbit created a ventilator based on manual resuscitation packs in June 2020. The ventilator features a number of sensors that may be used to monitor patients and regulate volume and pressure in relation to sensors.